Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Total Debt: 2021-2024

Historic Total Debt for Biofrontera (BFRI) over the last 1 years, with Jun 2024 value amounting to $296,000.

  • Biofrontera's Total Debt was N/A to $296,000 in Q2 2024 from the same period last year, while for Jun 2024 it was $13.8 million, marking a year-over-year change of. This contributed to the annual value of $3.9 million for FY2023, which is 43.76% down from last year.
  • According to the latest figures from Q2 2024, Biofrontera's Total Debt is $296,000, which was down 87.43% from $2.4 million recorded in Q1 2024.
  • Biofrontera's Total Debt's 5-year high stood at $7.2 million during Q3 2023, with a 5-year trough of $296,000 in Q2 2024.
  • For the 3-year period, Biofrontera's Total Debt averaged around $4.4 million, with its median value being $3.9 million (2023).
  • In the last 5 years, Biofrontera's Total Debt surged by 122.42% in 2023 and then crashed by 66.51% in 2024.
  • Quarterly analysis of 4 years shows Biofrontera's Total Debt stood at $3.2 million in 2021, then skyrocketed by 114.13% to $6.9 million in 2022, then tumbled by 43.76% to $3.9 million in 2023, then plummeted by 66.51% to $296,000 in 2024.
  • Its Total Debt stands at $296,000 for Q2 2024, versus $2.4 million for Q1 2024 and $3.9 million for Q4 2023.